Increasing Access to Biosimilars Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 28, 2021)
Increasing Access to Biosimilars Act of 2021
This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.
What just happenedApr 29, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 28, 2021
- Apr 29, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 28, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 28, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 28, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 28, 2021IntroReferralIntro-H
Introduced in House
- Apr 28, 2021IntroReferral1000
Introduced in House